Objectives: This prospective randomized trial evaluates the impact of early abciximab administration on angiographic and left ventricular function parameters.
目的：本前瞻性、随机试验旨在评价早期使用阿昔单抗对血管造影及左室功能参数的影响。
Background: Pooled data from randomized controlled trials suggest that the use of abciximab may be associated with a survival advantage in patients undergoing primary PCI for acute STEMI.
背景——来自随机对照试验的汇萃数据表明，因急性ST段抬高型心肌梗塞行直接PC I术后的患者，使用阿昔单抗可以提高生存率。
Background: Pooled data from randomized controlled trials suggest that the use of abciximab may be associated with a survival advantage in patients undergoing primary PCI for acute STEMI.
背景——来自随机对照试验的汇萃数据表明，因急性ST段抬高型心肌梗塞行直接PC I术后的患者，使用阿昔单抗可以提高生存率。
应用推荐